The WuXi PharmaTech and Mayo Clinic-backed aging disease drug developer floated at the midpoint of its range.

The sleep apnea developer, backed by Medtronic and Johnson & Johnson, floated at the top of its range before seeing its stock rise 56% on the first day.

The Qualcomm and NGP-backed electronics producer is reportedly seeking a $100bn valuation for the Hong Kong offering.

The corporate-backed pharmaceutical developers had aimed to raise a total of $155m from offerings they filed for in March.

The Kraft Group-backed spinal muscular atrophy drug developer has raised more than $100m in funding since 2012.

The e-signature technology provider's shares have risen almost 50% since it floated on Friday, illustrating that IPOs are back with a bang for tech companies.

The Samsung Ventures-backed laser manufacturing technology developer popped 56% after floating above its range last week.

Printing services provider Raksul, which has raised more than $68m from backers including Gree, Opt, GMO, Itochu, Plus, Mixi, Yahoo Japan and Nippon Life, will list in Tokyo.

Changcheng Investment Partners is an independent firm sponsored by Baidu and managed by its ex-CFO that will target internet and artificial intelligence.

Comcast Ventures and GV are both selling shares in an upsized offering that will give the digital signature technology developer a $4.4bn market cap.